Home » Newsletters » BioWorld Science

BioWorld Science

March 3, 2010

View Archived Issues

Dual IL-4/IL-13 receptor antagonist AER-003 reduces AHR in primates

Phase III data support use of mannitol test to identify EIB and asthma in children

Maraviroc analogue UK-484900 inhibits AHR in mice

Concert Pharmaceuticals discloses deuterated dual SV2A/Na channel blockers

Phase III data support icatibant safety and efficacy in acute HAE

Clinical data support combination of oxymetazoline and mometasone furoate for nasal congestion

Rigel identifies AXL kinase inhibitors for cancer therapy

BioDelivery Sciences presents update on BEMA Buprenorphine

Memory and Roche discover new PDE4 inhibitors

Neuraxon identifies nNOS inhibitors as analgesics

Bayer Schering claims new polo-like kinase 1 inhibitors

Antares completes enrollment in phase III Anturol trial in overactive bladder

EMA accepts voclosporin for regulatory review

Inovio to begin clinical trial of H5N1 flu DNA vaccine in Korea

InterMune submits MAA for pirfenidone for treatment of idiopathic pulmonary fibrosis

Synta resumes clinical development of elesclomol

Astellas commences tender offer to acquire OSI Pharmaceuticals

Shionogi and QuatRx to market and develop ospemifene

FDA reschedules meeting on ChemGenex's application for Omapro in CML

Renovo and Shire revise licensing deal for Juvista

FDA recommends approval of Bristol-Myers Squibb's belatacept

Celsion to begin phase II trial of ThermoDox and RFA for colorectal liver metastases

Orphan drug designation for Lithera's LIPO-102

Lundbeck inlicenses marketing rights to Azilect in Asian countries

Abbott and Enanta advance their hepatitis C collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...